Jump Financial »

Prelude Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $32k 16k 2.06
2021-12-31 $459k 37k 12.44
2021-06-30 $392k 14k 28.61
2021-03-31 $273k 6.3k 43.33

More positions owned by Jump Financial

SPDR S&P 500 ETF Trust Etf (SPY)
iShares Core S&P 500 ETF Etf (IVV)
Tesla Common Stock (TSLA)
Vanguard S&P 500 ETF Etf (VOO)
iShares 20 Year Treasury Bond ETF Etf (TLT)
Meta Platforms Common Stock (META)
Invesco QQQ Trust Series 1 Etf (QQQ)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Microsoft Corp Common Stock (MSFT)
Intercontinental Exchange Common Stock (ICE)
NVIDIA Corp Common Stock (NVDA)
Berkshire Hathaway Common Stock (BRK.B)
Intel Corp Common Stock (INTC)
Thermo Fisher Scientific Common Stock (TMO)

View all positions for Jump Financial

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Boxer Capital Management
BlackRock
T. Rowe Price Associates
Vanguard Group
Jacobs Levy Equity Management
Renaissance Technologies
Massachusetts Financial Services
Acadian Asset Management
Millennium Management
Geode Capital Management
Marshall Wace
Morgan Stanley
Two Sigma Advisers

View all funds holding Prelude Therapeutics